Press Releases

RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy

HAYWARD, Feb. 2, 2023 /Business Wire/ –(BUSINESS WIRE)–RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable for early and late-stage cancers. The company will host a live-stream event featuring both its co-founder and CEO discussing the breakthrough significance of SCINTIX therapy for cancer treatment. Read More…